Boston Biomedical is Drug Discovery in United States that focus on global clinical trials business. Founded in 2006. They cover business area such as developer, novel cancer therapeutic, patient outcome, expertise, drug discovery, external innovation partnership, medicinal chemistry, preclinical development, pharmacology, pharmaceutical development, CMC, manufacturing, control, global clinical trial, regulatory affair, commercialization, physician, novel therapeutic.
2006
( 18 years old in 2024 )
Global Clinical Trials
-
640 Memorial Drive
Cambridge, MA 02139
United States
Private
developernovel cancer therapeuticpatient outcomeexpertisedrug discoveryexternal innovation partnershipmedicinal chemistrypreclinical developmentpharmacologypharmaceutical developmentCMCmanufacturingcontrolglobal clinical trialregulatory affaircommercializationphysiciannovel therapeutic
* We use standard office opening hours in near Boston Biomedical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Boston Biomedical is Drug Discovery business from United States that founded in 2006 (18 years old in 2024), Boston Biomedical business is focusing on Global Clinical Trials.
Boston Biomedical headquarter office and corporate office address is located in 640 Memorial Drive Cambridge, MA 02139 United States.
Boston Biomedical was founded in United States.
In 2024, Boston Biomedical is currently focus on global clinical trials sector.
Above is snippet of Google Trends for "global clinical trials" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Boston Biomedical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
